Hostname: page-component-669899f699-qzcqf Total loading time: 0 Render date: 2025-04-27T02:22:25.506Z Has data issue: false hasContentIssue false
  • English
  • Français

The Role of Institutional Epidemiologic Weight in Guiding Infection Surveillance and Control in Community and Hospital Populations

Published online by Cambridge University Press:  21 June 2016

David M. Hartley ,
Jon P. Furuno ,
Marc O. Wright ,
David L. Smith  and
Eli N. Perencevich
David M. Hartley*
Affiliation:
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Jon P. Furuno
Affiliation:
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Marc O. Wright
Affiliation:
University of Maryland Medical Center, Baltimore, Maryland
David L. Smith
Affiliation:
Fogarty International Center, National Institutes of Health, Baltimore, Maryland
Eli N. Perencevich
Affiliation:
VA Maryland Health Care System, Baltimore, Maryland
*
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 660 West Redwood Street, Baltimore, MD 21201 (dhartley@epi.umaryland.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

Institutions such as hospitals, prisons, and long-term care facilities have been identified as focal points for the transmission of emerging infections. Cost-effective control of these infections in large populations requires the identification of optimal subpopulations for targeted infection control interventions. Our objective was to quantify and compare the relative impact that individual institutions or subpopulations have on wider population-level outbreaks of emerging pathogens.

Design.

We describe a simple mathematical model to compute the epidemiologic weight (EW) of an institution or subpopulation. The EW represents the rate at which newly infectious individuals exit the institution under consideration.

Setting.

A hypothetical academic tertiary-care hospital (700 beds, 5-day length of stay [LOS]) and prison (3098 inmates, 27-day LOS).

Patients.

Individuals entering a hospital in-patient prison ward and nonprisoners entering both medical and surgical intensive-care units and those admitted to the general medical and surgical wards.

Results.

The recent example of the community-acquired methicillin-resistant Staphylococcus aureus epidemic is used to illustrate the EW calculation. Hospitals and prisons, which often have vastly dissimilar populations sizes and LOSs and might have differing transmission rates, can have comparable EWs and thus contribute equally to an epidemic in the community.

Conclusions.

This method highlights the importance of measuring entrance and exit colonization prevalences for the optimal targeting of prevention measures. The EW not only identified superspreader institutions but also ranks them, enabling public health workers to optimize the allocation of resources to places where they are likely to be of most benefit.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 2 , February 2006 , pp. 170 - 174
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Vandenesch, F, Naimi, T, Enright, MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978–984.Google Scholar
2.McDonald, LC, Kuehnert, MJ, Tenover, FC, Jarvis, WR. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis 1997; 3:311–317.Google Scholar
3.Wise, RI, Ossman, EA, Littlefield, DR. Personal reflections on nosocomial staphylococcal infections and the development of hospital surveillance. Rev Infect Dis 1989; 11:1005–1019.Google Scholar
4.Livermore, DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2000; 16(Suppl 1):S3–S10.Google Scholar
5.Mundy, LM, Fraser, VJ. Determining the cost-effectiveness of healthcare epidemiology and infection control programs. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott, Williams & Wilkins; 2004:1827–1834.Google Scholar
6.Smith, DL, Dushoff, J, Perencevich, EN, Harris, AD, Levin, SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A 2004; 101:3709–3714.Google Scholar
7.Pan, ES, Diep, BA, Carleton, HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003; 37:1384–1388.Google Scholar
8.Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:919–922.Google Scholar
9.Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52:992–996.Google Scholar
10.Wright, MO, Venezia, R, Johnson, JK, et al. Methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients transferred from correctional facilities (CF): the Maryland experience. In: Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 30-November 2, 2004; Washington, DC. Abstract ICAAC04-A-1104-ASM.Google Scholar
11.Furuno, JP, McGregor, JC, Harris, AD, et al. Identifying patients at high risk for colonization by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) upon hospital admission: use of a clinical prediction rule (abstract 24). Paper presented at the 15th Annual Meeting of the Society of Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA.Google Scholar
12.Lowy, FD, Miller, M. New methods to investigate infectious disease transmission and pathogenesis—Staphylococcus aureus disease in drug users. Lancet Infect Dis 2002; 2:605–612.CrossRefGoogle ScholarPubMed
13.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362–386.Google Scholar
14.Eveillard, M, Martin, Y, Hidri, N, Boussougant, Y, Joly-Guillou, ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004; 25:114–120.Google Scholar
15.Lucet, JC, Grenet, K, Armand-Lefevre, L, Harnal, M, Bouvet, E, Regnier, B, Andremont, A. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005; 26: 121–126.Google Scholar
16.Smith, DL, Dushoff, J, Morris, JG. Agricultural antibiotics and human health. PLoS Med 2005; 2:e232.CrossRefGoogle ScholarPubMed